Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yang Feng
Observed institutions:
University of Florida Health,
University of Florida,
Stanford Medicine,
UF Health Cancer Center,
Institute for Stem Cell Biology and Regenerative Medicine,
Stanford University
show all 6
ORCID:
0000-0002-9533-1501
Observed ORCID:
0000-0002-9533-1501
OpenAlex ID:
A5061591233
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia
2021
·
Ganqian Zhu
, Huacheng Luo
, et al.
·
Nature Communications
·
79
PDF
Alterations to DNMT3A in Hematologic Malignancies
2020
·
Kartika Venugopal
, Yang Feng
, et al.
·
Cancer Research
·
71
Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer
2023
·
Yang Feng
, Qingchen Yuan
, et al.
·
The Journal of Experimental Medicine
·
31
PDF
IDH1 -Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation
2023
·
Niklas Landberg
, Thomas Köhnke
, et al.
·
Blood Cancer Discovery
·
23
DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication Forks
2021
·
Kartika Venugopal
, Yang Feng
, et al.
·
Clinical Cancer Research
·
23
miR-196b–TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A -Mutant AML
2022
·
Holly A. Gamlen
, Jennifer S. Romer-Seibert
, et al.
·
Clinical Cancer Research
·
19
PDF
Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations
2022
·
Daniil E. Shabashvili
, Yang Feng
, et al.
·
Experimental Hematology
·
14
DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
2025
·
Thomas Koehnke
, Daiki Karigane
, et al.
·
Cancer Discovery
·
7
PDF
Dnmt3a Mutations in the Hematopoietic System Promote Colitis-Associated Colon Cancer: A Model of Clonal Hematopoiesis in Solid Tumors
2021
·
Yang Feng
, Rachel Newsome
, et al.
·
Blood
·
4
DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents
2020
·
Heidi L. Casellas Román
, Kartika Venugopal
, et al.
·
Leukemia Research
·
4
Inhibition of DOCK1 prevents the clonal expansion of high-risk TP53-mutant clonal hematopoiesis induced by genotoxic stressors.
2025
·
Yang Feng
, Thomas Koehnke
, et al.
·
Blood
·
2
PDF
Optimized Mouse Model to Induce Colitis-Associated Colon Cancer using Azoxymethane and Dextran Sulfate Sodium for Tumor Immunology and Therapy Studies
2025
·
Yang Feng
, Qingchen Yuan
, et al.
·
Journal of Visualized Experiments
·
2
Gene Correction of DNMT3A:R882H in Primary Human AML Demonstrates That This Mutation Is Not Required for Disease Maintenance, but Is Associated with Increased Leukemia Stem Cell Frequency
2023
·
Thomas Koehnke
, Daiki Karigane
, et al.
·
Blood
·
2
PDF
DNMT3A with Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication Forks
2019
·
Kartika Venugopal
, Daniil E Shabashvili
, et al.
·
Blood
·
2
Cells with DNMT3A Mutations Are More Sensitive to Cytarabine-Induced DNA Damage
2018
·
Kartika Venugopal
, Jianping Li
, et al.
·
Blood
·
2
A new era of functional experimentation in human hematopoiesis and leukemia research
2024
·
Thomas Köhnke
, Yang Feng
, et al.
·
Experimental Hematology
·
1
Supplementary Figures 1-6 from IDH1-Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation
2024
·
Niklas Landberg
, Thomas Köhnke
, et al.
·
1
Supplementary Table S8 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
2026
·
Thomas Köhnke
, Daiki Karigane
, et al.
Supplementary Table S7 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
2026
·
Thomas Köhnke
, Daiki Karigane
, et al.
Supplementary Data S2 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
2026
·
Thomas Köhnke
, Daiki Karigane
, et al.
Supplementary Table S2 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
2026
·
Thomas Köhnke
, Daiki Karigane
, et al.
Supplementary Table S1 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
2026
·
Thomas Köhnke
, Daiki Karigane
, et al.
Supplementary Table S6 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
2026
·
Thomas Köhnke
, Daiki Karigane
, et al.
Supplementary Data S4 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
2026
·
Thomas Köhnke
, Daiki Karigane
, et al.
Supplementary Figures S1-S11 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
2026
·
Thomas Köhnke
, Daiki Karigane
, et al.
Show more works
View as search
Works count:
73
Citation count:
287
H-index:
7
I10-index:
7
Year
Topic
Type
